ArticleNephrology (Carlton, Vic.)2025
Registry-Based Living Kidney Donor Follow-Up in Australia: An ANZLKD Analysis 2003-2021.
Article in Nephrology (Carlton, Vic.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Breaking barriers: A decade-long institutional journey to sustain mandated living kidney-donor follow-up in Qatar.Qatar medical journal · 2026Review
- Registry-Based Living Kidney Donor Follow-Up in Australia: An ANZLKD Analysis 2003-2021.Nephrology (Carlton, Vic.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Australia and New Zealand Live Kidney Donor (ANZLKD) Registry is the binational registry for recording live kidney donor outcomes in Australia and New Zealand. In this retrospective analysis, it is demonstrated that only 2.93% of living kidney donors in Australia across 2004-2021 have adequate follow-up data recorded in ANZLKD. Response rates recorded through ANZLKD gradually decline from year after donation, starting at 38% at 1 year and reaching 1.6% at 15 years. Factors associated with adequate follow-up in ANZLKD included reduced eGFR and later donation year. This is amongst the first studies to objectively assess kidney donor follow-up recorded in ANZLKD and highlights a critical gap in binationally documented donor follow-up and outcome monitoring in live kidney donors. This study highlights the urgent need to improve live kidney donor data input in ANZLKD and/or live kidney donor follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.